Classification of colon adenocarcinoma based on immunological characterizations: Implications for prognosis and immunotherapy.
Xu M, Chang J, Wang W, Wang X, Wang X, Weng W, Tan C, Zhang M, Ni S, Wang L, Huang Z, Deng Z, Li W, Huang D, Sheng W.
Xu M, et al. Among authors: ni s.
Front Immunol. 2022 Jul 27;13:934083. doi: 10.3389/fimmu.2022.934083. eCollection 2022.
Front Immunol. 2022.
PMID: 35967414
Free PMC article.